Introduction
Cancer treatment generally comes in four modalities.' Traditionally, surgery of tumours was the most important, while radiotherapy, chemotherapy and immunotherapy were introduced as new forms of treatment in the course of the twentieth century. Although chemotherapy and immunotherapy did not become standard until after the Second World War, X-rays and radium were used as alternatives to the surgical knife in eliminating cancer cells soon after their discovery at the end of the nineteenth century.2 This essay is concerned with the way in which radiotherapy for the treatment of cancer took shape, especially in Germany, in the first decades of the twentieth century. The analysis concentrates on two aspects.
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The first is that of the struggle between the representatives of orthodox medicine, those using the scalpel in the fight against cancer, that is to say, general surgeons, internists, gynaecologists, dermatologists and oto-laryngologists, and those who perceived in rays a new, separate form of treatment of the cancer patient, i.e. the radiotherapists-to-be. When X-rays and radium were found to be effective in the combat against cancer, radiotherapists sought to create their own niche within the existing ecology of medical professions. In his System ofprofessions, Andrew Abbott argues that the establishment of a profession is best analysed in terms of tasks, jurisdiction and competition.3 The present essay illustrates that this "infighting" over radiotherapy took the form of a struggle for the cancer patient and for jurisdiction over the use of the new techniques such as X-rays and radium.
The second focus of this essay is the role of costly instruments and resources and their impact on the organization of therapy. X-rays as well as radium could be deployed as small-scale or large-scale techniques. Their first therapeutic applications were small-scale, viz, X-ray tubes which had already been used for diagnostics were now applied therapeutically by merely extending the duration of the application; radium was used in milligram quantities for superficial tumours. In the 1920s, however, a breakthrough took place. The X-ray instruments were now operated at several hundreds of kilovolts, and so-called radium bombs or canons, containing several grams of radium, were designed for cancer therapy. In addition, more knowledge was available on the risks accompanying these techniques, for example those of skin burns or tumours. These specific conditions stimulated the establishment of large centralized institutes for cancer treatment and cancer research. At the 1926 congress on 'Cancer Control', held at Lake Mohonk, New York, Claude Regaud, director of the "Therapeutic Service" of the Paris-based Curie Foundation claimed that the developments outlined above indicated the necessity of:
. . . calling in for the examination and treatment of patients, men of various specialties whose work must be exactly co-ordinated; of placing at the service of diagnosis and treatment different kinds of laboratories, all well equipped; of bringing together special X-ray apparatus which is numerous, heavy, and costly to purchase and maintain; of employing large quantities of radium-all this explains adequately the recent organization of anti-cancer therapy with a view to a work that is to be accomplished by a collective staff, in special, well-endowed establishments.4
In France, England, Sweden and the United States such centralized cancer institutes were indeed established in the first decades of the twentieth century, mainly supported by huge philanthropic donations. Although even in these specialized establishments a certain degree of rivalry would have existed between radiotherapists and medical specialists such as surgeons, intemists and gynaecologists, these institutes were instrumental in establishing radiotherapy as an independent profession and in the 'Andrew Abbott, The system ofprofessions:
and X-Rays?', in American Society for the an essay on the division of expert labor, University Control of Cancer, Cancer control, Chicago, of Chicago Press, 1988 . Surgical Publishing Co., 1927 120.
'Claude Regaud, ' What is the value and what should be the organization and equipment of institutions for the treatment of cancer by radium development of a multi-disciplinary approach to cancer treatment. In Germany, however, radiotherapy lacked a centralized organization until well after the Second World War, and fell under the jurisdiction of various specialities such as surgery and gynaecology. This delay in the centralization of German radiotherapy has been generally acknowledged.5 In 1959, the Swiss radiologist Hans R Schinz stated that in the organization of radiotherapy "Germany, Rontgen's homeland, has curiously dropped behind".6 And in a discussion of the development of German medical disciplines, Hans-Heinz Eulner concluded in regard to radiotherapy that the Anglo-Saxon and Scandinavian countries and Switzerland were quite advanced in the centralization of radiotherapy while in Germany "the clinicians had opted for the principle of decentralization".7 Thus, German radiotherapy and specialized cancer institutes became institutionalized relatively late in comparison to countries such as France, England, Sweden and the United States.8
The conflicts over the introduction of radiotherapy in Germany are well documented by archival and published sources, because during the 1930s a struggle developed over the Institut fur Krebsforschung (Institute for Cancer Research; hereafter IfK) of the Berlin Charite hospital. At that time, the IfK was led by the Jew Ferdinand Blumenthal (1870 -1941 , who had also been deputy head when the Institute was established in 1903 by Ernst von Leyden. Von Leyden, who had been a professor of internal medicine in StraBburg before he was appointed head of the First Medical Clinic of the Charite in 1885, was Germany's leading internist and became the first director of the IfK. After a period in which the Institute was led by others, Blumenthal had become director in the mid-1910s, and in the late 1920s he worked towards the centralization and regulation of German cancer control in general and of radiotherapy in particular. In this he was supported by the ReichsausschuB fur Krebsbekampfung (State Committee for Cancer Control), which was inaugurated in 1931, signalling the first definite involvement of the German state in this aspect of public health. Blumenthal's desire for centralization, backed up by the ReichsausschuB, met with powerful resistance from other Charite clinics, the medical faculty of Berlin University and the German societies for surgery and gynaecology. In the early 1930s, the latter specialists successfully penetrated the ReichsausschuB, and National Socialist measures against Jews helped to ensure the neutralization of attempts to centralize radiotherapy in Germany and to establish one or two national cancer institutes.
Thus, the actual development of radiotherapy in Germany differed from that in 5On German radiotherapy, see Hans-Peter 7Hans-Heinz Eulner, 'Rontgenologie', in idem, Heilmann, 'Radiation oncology: historical Die Entwicklung der medizinischen Spezialfacher development in Germany', Int. J. Radiat. OncoL, an den Universitaten des deutschen Sprachgebietes, Biol., Phys., 1996, 35: 207-17, pp. 207-9. See also Stuttgart, Ferdinand Enke, 1970, pp. Berlin, Springer, 1989 . Thieme, 1959 Ton van Helvoort countries such as France, England, Sweden and the USA. It will be argued below that this was related to the strength of German orthodox specialists, the costly nature of radium and the lack of German resources for radioactive substances, as well as to the absence of a philanthropic tradition with regard to cancer control and research and the reluctance of the German state to support the latter.9 It must be admitted that the tension between surgeons and medical specialists on the one hand and radiotherapists on the other about the jurisdiction over the new cancer treatment modalities occurred in all countries, but the specifics of the German situation made the disaccord more visible and the consequences more enduring.
Introducing Radiotherapy into Cancer Treatment
In the late nineteenth century, surgery was the standard treatment of cancer and had achieved a high level of perfection. The possibility of general anaesthesia had lessened the fear of operations and also allowed them to last longer. Furthermore, under the influence of the work of Joseph Lister, Louis Pasteur and Robert Koch, the use of antiseptics and a strictly aseptic protocol had ameliorated mortality and morbidity.'0 Surgical intervention in cancer was based on the consideration that early cancer was a local disease and only in a later phase did the tumour cells spread via the lymph nodes, after which the disease could establish itself in other organs (metastasis)."
In the first decades of the twentieth century, cancer patients constituted a quarter of the surgeon's patients.'2 For gynaecologists too, the treatment of cancer patients made up a substantial part of their daily activities. Exterior forms of gynaecological cancer, e.g. breast cancer, were relatively simple to deal with surgically. In many cases of cervical cancer, however, the tumour was difficult to access through the vagina. This mode of operation resulted in a high percentage of relapses, i.e. patients in whom the tumour returned or metastasis was not prevented. Difficult cases of cervical cancer were often approached via the abdominal wall (laparotomy), a major operation in which the chance of recovery was heavily influenced by the woman's constitution.'3 In addition to these difficulties, there were many inoperable cases of cancer patients whose tumours were too large to be removed surgically or had fused with surrounding organs and tissues. Clearly there was need for an alternative to the scalpel.
In late 1895, Wilhelm C Rontgen reported that, while working with a cathode tube, he had observed a new kind of rays.'4 These he denoted as "X-rays", to indicate that ', Minerva, 1997, 35: 283-93. '3Walter Stoeckel, Erinnerungen eines '°For the role of surgery in cancer, see, for
Frauenarztes, Leipzig, S Hirzel, 1979, pp. 109-10 . instance, George J Hill, II, 'Historic milestones in Gerald L'E Turner, 'Rontgen, Wilhelm cancer surgery', Semin. Oncol., 1979, 6: 409-27. Conrad', in C C Gillispie (ed.), Dictionary of " Cf. Charles P Childe, The control of a scientific biography, vol. 11, New York, Charles scourge, or, how cancer is curable, New York, E P Scribner's Sons, 1981 , pp. 529-31. Dutton, 1907 Radiotherapy in Pre-Second World War Germany their nature was still unknown. Rontgen observed that these rays could pass through the fleshy part of a hand but were attenuated by bones. The visualization of the inside of the body would prove to have an enormous impact on medicine, and even on the image man had ofhimself. 5 Within diagnostics, X-rays were used in three ways, namely in trauma medicine, bone diseases and fractures, and the search for corpora alienum such as bullets (Fremdkorpersuche) . Therefore, X-ray diagnostics were applied mostly within surgery, orthopaedics and internal medicine. Each specialism claimed the application of the X-ray technique to its own field of competence. '6 In the early years of the twentieth century, the Surgical Clinic as well as the First and Second Medical Clinics of the Charite obtained their own X-ray departments. to radiotherapy in the treatment of cancer, an attitude that was not shared by many surgeons. Although many cancer patients were in a poor condition already, surgeons often did not hesitate to burden them with an exhausting operation. Much was at stake in the competition between surgery and radiotherapy: the status and authority of surgery with regard to cancer treatment, as well as certain financial interests.
As indicated above, most medical specialists were familiar with the technique of X-ray diagnostics. The move from X-ray diagnostics to X-ray therapy seemed to be only a quantitative change. In the early years, for instance, X-ray therapy of cervical cancer was performed by the simultaneous application of two X-ray tubes placed on the abdomen and directed at the cervix, and a third one irradiating the cervix through the vagina. Munich, Urban & Schwarzenberg, 1959. Radiotherapy in Pre-Second World War Germany period.26 In addition to X-ray therapy, however, there was a second type of radiation used in the treatment of tumours, namely "radium therapy".
Radium Therapy in Germany
In the context of the discovery of X-rays and their presumed relation to phosphorescence, Antoine-Henri Becquerel made a study of uranium salts. During one of these experiments, in early 1896, he discovered a new form ofradiation.27 This discovery was elaborated upon by Marie (Sklodowska-)Curie who used a piezo-electrometer developed by her husband Pierre Curie to study whether this kind of radiation also emanated from other elements. She found that thorium compounds gave evidence of the same property, and this new form of energy from uranium and thorium she named radioactivity. Subsequently she found that pitchblende (uraninite; Uranpecherz) produced more radioactivity than could be explained on the basis of its uranium content. Apparently, a further radioactive substance had to be present, and her research resulted in the isolation of the element polonium, the discovery of which was announced in July 1898. Subsequently, a second element was isolated, which was named radium (announced in December 1898) and possessed 2 million times more radioactivity than uranium. The fact that one part of radium had to be isolated from 4 million parts of pitchblende meant that enormous investments had to be made to isolate enough. At that time, the only uranium mine was to be found in Joachimstal, Bohemia, which was then under the authority of Austria (it is now part of the Czech Republic).28
The therapeutic effect of X-rays on dermatological disorders (for instance, lupus) stimulated the application of radium to this kind of disease as well.29 The application of radium to dermatology and benign tumours promptly resulted in striking improvements. Radium therapy was even used to heal skin lesions that had resulted from X-ray bums. Success was reported with malignant tumours too. Deeply situated tumours could be caused to regress by placing tubes containing radium inside the tumour (interstitial radium implantation).30
Since the supplies ofuranium were limited, as a consequence ofradium's therapeutic application, the price skyrocketed. In 1911, radium was found in carnotite (vanadium oxide) in Colorado (USA), which meant that an important additional source had become available. In Germany, however, the shortage of radium was dire.
In 
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Solz to report on the availability of radium in Germany for the treatment of cancer.3' Ehrlich argued that one metric ton of Uranpecherz of the best quality yielded only 0.2 grams of radium. The ore from Joachimstal had this quality and the French also had a radium production facility at Nogent-sur-Marne. The only German producer was Buchler & Co. at Braunschweig, and the only German uranium ore was mined at Kreuznach, Bad Dtirkheim and Baden-Baden, but it was of a much lower grade. German scientists did manage to find an alternative for radium, however. From the residues of the production of thorium for gas mantles, the radioactive substance mesothorium could be extracted, which was also useful for radiotherapy.32
In a 1909 letter to the German Emperor, von Trott zu Solz presented an outline of the distressing situation regarding the availability of radium for cancer treatment in Germany.33 In this report the world supply of radium (in the form of radium bromide) was assessed at 9 grams, of which one-third was under Austrian authority. Two grams were held in the Institute of Physics at Vienna, while three-quarters of a gram were on loan to England. In Paris, Marie Curie had one to one and a half grams, while the rest was distributed over numerous institutes all over the world. The worrisome situation for Germany is clear from the following summary: in Berlin the Akademie der Wissenschaften (Academy of Sciences) held 27 mg semi-pure and 8 mg pure radium bromide, while even less was available at the Charite and at the Technical University. Von Trott zu Solz argued that one quarter of a gram was urgently needed to keep up with ongoing research. As the price of 1 mg radium bromide had risen from 12 Marks to 150 Marks over the previous decade, the Emperor was asked to make available 37,500 Marks for the purchase of that quarter of a gram, which was to be supplied by the Chininfabrik Buchler & Co. at Braunschweig.
In response to the excitement caused by Kronig's presentation at the Congress of Gynaecologists, August von Wassermann, who had devised the serological test for syphilis which was named after him, was asked in the same year to evaluate cancer treatment by radium and mesothorium.34 Wassermann stated that the results obtained by treating tumours with rays emitted by radium or mesothorium were most promising and that clinicians were already becoming bold enough to speak of "curing" cancer. However, the action of these rays had to be a direct one, meaning that radioactive rays were ineffective where the tumour had already metastasized and the tumour cells had spread through the body. Wassermann reported that the gynaecologist Kronig made use of 400 to 500 mg of radioactive substance. He also stated that the production of mesothorium, the alternative for radium, was difficult Radiotherapy in Pre-Second World War Germany and costly. The German Glihlicht Gesellschaft (Gas Mantle Company) had an annual production of 2 g, and in 1913 each mg cost 200 to 300 Marks. 35 Because of the price and scarcity of mesothorium, it was suggested in the press that its production should perhaps be brought under public ownership. Von Trott zu Solz advised the Emperor regarding the medical use of radioactive substances.36 He stated that medical treatment required at least a sample of 200 mg of radium or mesothorium (which could of course be used repeatedly) and that "the areas of gynaecological disorders, surgery, skin and venereal diseases, internal medicine and ear, nose and throat diseases" were proper fields of use. In cases where radiotherapy did not cure, it was at least effective in killing pain, which was a valuable application of these substances in itself. Therefore, the Minister of Science had acquired 1250 mg of radium and 250 mg of mesothorium for a total sum of 500,000 Marks. As regards the nationalization of mesothorium production, von Trott zu Solz had himself been advised by Germany's most renowned chemists and physicists, Otto Hahn, Emil Fischer and Walther Nernst. The latter arrived at the following conclusions.
Mesothorium was produced from monazite, which was mined only in Brazil. From 1 metric ton of monazite, 2 to 2.5 mg mesothorium was produced. If mesothorium was to be produced by the state, it would cost 320 to 400 Marks per mg, which was about twice the price current at that moment. Furthermore, numerous production installations would have to be bought, as well as compensation paid for the various patents to the companies affected.37 Worldwide, about 7 grams of mesothorium were produced each year, ofwhich about 5 grams were extracted in Germany. Furthermore, there was the real possibility that Brazil would work up mesothorium by itself, just as Austria had done with the production of radium. In a report to the Ministerialdirektor (secretary general), Naumann, Walther Nernst therefore urged that the usefulness of mesothorium should not be made public: "Let us hope the German press will not make too much of the importance of mesothorium, as this might lead to increases in the price that German industry has to pay for the raw material, i.e., monazite."38 But there were other arguments for not bringing the production of mesothorium under public ownership. First, there was the real possibility that radioactive substances would shortly be produced artificially. Furthermore, in a report to von Trott zu Solz, the organic chemist Emil Fischer argued that in the near future tumours could perhaps be destroyed by making use of X-rays or chemotherapy, which implied that radium and mesothorium would no longer be indispensible. Fischer Krebsforschung, 1903 Krebsforschung, -1928 The successes of medical science, and bacteriology in particular, during the last decades of the nineteenth century stimulated a renewed attack on cancer. Despite the progress of pathology, the cause of cancer still was a mystery. In 1900 the decision was taken in Germany to organize a census or Sammelforschung regarding cancer, in order to investigate whether proof could be obtained of the infectious nature of the disease. Chaired by Ernst von Leyden, head of the First Medical Clinic of the Charite, the Komitee fur Krebsforschung (Cancer Research Committee) was founded. At its inauguration, von Leyden declared himself a proponent of the parasitical hypothesis in the question of cancer etiology: "The theory which is now gaining prominence, and to which I myself fully subscribe, is that of the parasitical nature of cancerous diseases. It is the only theory which is in sufficient agreement with the observations and with current biological views."' Even under Georg Klemperer, the IfK had been in need of an outpatient clinic in order to contact patients as soon as possible, and to intervene in the disease process in its earliest stages. This would allow the latest diagnostic methods and therapies to be tried and evaluated. In 1911, Klemperer therefore asked Naumann for permission to open an outpatient clinic, arguing that there was a special need for patients who had not yet been clearly diagnosed with cancer. Sometimes it took several weeks before the decision was made to operate, and meanwhile the ambulant patient could be diagnosed in more detail. Subsequently, surgery could be performed at the surgical clinic. Klemperer emphasized that until then the IfK had mostly received patients who were in a desperate condition. The reason was that the intake of patients was indirect, through referral from the other Charite institutes. This resulted in a situation "in which our patients come from clinics which allow them to come here only after they have lost any practical medical or scientific interest in them and when only the human aspect of euthanasia can be considered".45 Ernst Piutter, the Verwaltungsdirektor (administrative director) of the Charite, underlined the IfK's need for patients in the "various stages of the disease" and therefore of a Poliklinik fuir Krebskranke und Krebsverdachtige (Outpatient Clinic for Cancer Patients and Cancer Suspects).' The IfK's wish was to be granted in 1915.
Klemperer's letter, quoted above, reveals a tension between the Institut fur Krebsforschung and the other specialist fields which were involved in cancer patient care, such as surgery, internal medicine and gynaecology. Klemperer hastened to state that the IfK would never admit patients to its beds who were operable; these were to be referred for surgery immediately. But there were also many tumours which were inoperable, such as those in the pleura, the lungs, the liver, spleen, thymus, stomach and, to some extent, in the intestine, as well as patients who had already been operated upon but who had suffered relapses (often cases of cancer of the breast or cervix). Klemperer was aware that an outpatient clinic would provoke opposition from the other Charite clinics, but gave the assurance that: "There would be no competition with the surgeons 43This argument is elaborated in Ton van Bekampfung der Krebskrankheit (1900 Krebskrankheit ( -1933 Ton van Helvoort whatsoever. Our department would select internal, inoperable cases or inoperable relapses of external cancers."47 (Emphasis as in the original.) After Blumenthal had been put in charge of the IfK, the relationship with the surgeons was one of careful manoeuvring. In a letter to the Minister fur Geistliche und Unterrichts-Angelegenheiten (Minister for Educational and Spiritual Affairs) Blumenthal wrote that a useful cooperation had been established between his Institute and the Surgical Clinic. Those patients who were operable were referred, while the surgical department "sends us the tumours removed at operation, and we use them to prepare a vaccine with which we immunize the patients in order to induce their bodies to form antibodies against tumour relapses".48 Although Blumenthal stated that the relationship with surgery was more or less harmonious, Naumann informed Blumenthal that the Charite was mounting fierce resistance against the Institute. Briefly, the argument was: "The scientific research was done in other institutes, while the cancer patients could be treated at the appropriate clinics." However, Blumenthal also experienced firm support from, for example, Johannes Orth of the Pathological Institute, who had been Blumenthal's supervisor when he started his career, as well as from Ernst Puitter and from Naumann himself.49
For its research into the etiology and treatment of cancer, the IfK thus needed patients in the early stages of the disease. On the other hand, even the desperate cases of inoperable cancer patients had to be offered some hope, otherwise they would seek help from quacks, homoeopaths, and so-called "biochemists".50 Blumenthal held the opinion that one had to fight cancer by, in current terminology, a multi-modality regime in which surgery, chemotherapy, radiotherapy and immunotherapy each made its own contribution. For Blumenthal, cancer treatment had to be comprehensive, with local control of tumours being implemented by surgery and radiation. This was supplemented by the systemic and constitutional treatment of the disease, in which chemotherapy and immunotherapy were additional treatment modalities, to aid the patient's convalescence. Except for smaller surgical manipulations, no substantial surgery took place at the IfK.5' Under Blumenthal's directorship, radiotherapy became the foundation of the Institute on the basis of which even the most desperately ill cancer patient could be offered a ray of hope for recovery and at least some form Krebsforschung', 1923, 19: 185-206. Radiotherapy in Pre-Second World War Germany of relief. This, however, was to bring Blumenthal and the IfK into conflict with those who used the scalpel as the main weapon against cancer.
That the IfK applied radiotherapy to a substantial number of patients with malignant and benign tumours is apparent from the numbers listed in Table 1 , covering treatment during the six years from 1922 until 1927.52 In spite of Blumenthal's reassurance that there would be no competition between his Institute and those clinics where cancer patients were traditionally taken care of, the above data show that such a tension was almost inevitable. Furthermore, Blumenthal had a critical attitude towards operating on a cancer patient. Relapses after operations were commonly explained on the basis that surgery had apparently been performed at too late a stage or that not all the cancer cells had been removed. Blumenthal, however, held the opinion that the body was able to destroy metastasized cancer cells through its immune system. But a major operation would exhaust the body and shift the balance of the struggle towards the cancer cell:53 Ton van Helvoort are distributed throughout the body, which are then stimulated to grow as the organism is weakened by the operation.
Obviously, the numbers in Table 1 leave unanswered the question of the therapeutic effect of radiotherapy at the IfK, and how this compared with the efficacy of surgery. As Ilana Lowy has shown, stringent clinical trials are a relatively recent phenomenon. Unsurprisingly, most pre-Second World War studies did not report comparative results.54
During the first decades of the twentieth century, surgery had a poor reputation and a diagnosis of cancer was perceived as a death sentence. One critic of surgery stated in the early 1930s: "Instead of telling us tales of the Arabian Nights, the surgeons and gynaecologists should tell us frankly how many patients treated by them were still alive 5, 10, 15 years afterwards."55 In 1933 the Wiirzburg surgeon Fritz Konig carried out a survey in which 60 hospitals were approached and 33 responded. Three thousand patients were reported to be free of tumours after five years, most of whom had been operated upon, while only a few had received no treatment apart from radiotherapy. Konig concluded that "even the most obdurate pessimist cannot doubt the effectiveness of surgery in cancer control".56
The Festschrift of the Institut fur Krebsforschung on its twenty-fifth anniversary did not contain figures about the efficacy of radiotherapeutic treatment. There are obvious reasons for this. First, radiotherapy was still in its developmental stage, so the technique was changing rapidly over time. Second, in 1939 the radiotherapist Otto Juingling from Kiel had analysed why comparative studies were so difficult to perform: the therapists had to work along strict rules of statistics; furthermore, the patients undergoing different treatments had to be in a similar clinical stage. According to Julngling, only centralized cancer institutes could satisfy such requirements: "Such exemplary reports are available from large centres in Stockholm, Paris and Zurich and from American authors".57
The question about the best treatment modality for cancer-surgery or radiotherapy?-led to tensions between those who operated rays and those who used the scalpel. This was the case in Germany as well as in other countries. However, the fact that X-ray and radium techniques were developed into expensive instruments, and that X-rays and radioactive substances were dangerous, stimulated the centralization of radiotherapy in large treatment centres, as well as the establishment of organizations for the administration of the radium supplies, the training of staff to handle X-rays and radioactive substances and the introduction of new legislation.
The virtual non-existence of cancer charities and the strong opposition to the centralization by medical specialists meant that radiotherapy took a different course in Germany to that in many other countries. 
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Philanthropy and Radium Therapy outside Germany This section presents a brief overview of the development of radium therapy in France, Sweden, the United States and Great Britain.58 In these countries, the high cost of radium played a crucial role in its control and in the centralization of radiotherapy.
In France, the Laboratoire Biologique du Radium (Biological Radium Laboratory) was established in 1906 under the auspices of Armet de Lisle, director of a radium factory, and in 1912 the Radium Institute came into being. One year later the University of Paris and the Pasteur Institute established a joint project on research into radiotherapy, giving three main reasons: (i) to link animal experiments with clinical research; (ii) to ameliorate the collaboration between surgeons and radiologists; (iii) because the new equipment was so costly that only co-operation could justify the large expense.59 The research into radium and its application was strongly stimulated when in 1921 Marie Curie received from the American Women's Movement a gift of 1 gram of radium. Furthermore, she was lent several grams of radium by the parent company of the Belgian Mines du Haut-Katanga (Upper Congo Mines). At Villejuif, a southern suburb ofParis, Gustave Roussy established a new cancer centre in 1920, which initially was small but soon saw major expansion. In the 1920s, a department oftelecurietherapy (Fernbestrahlung, Tieftherapie, deep therapy) had been established here, headed by Simone Laborde, in which use was made of a "radium bomb" containing 10 grams. In the late 1920s, only six of these instruments, containing such a massive amount of radium, were operational and two of them were located in Paris, one in Villejuif and the other at the Radium Institute.60
In Sweden, Tor Stenbeck and Tage Sjogren were the founding fathers of radiotherapy. They started with self-made X-ray machines, which were used for diagnostics as well as for therapy. One of Stenbeck's pupils, Gosta Forssell, was to become the Nestor of Swedish radiotherapy. He worked at the Serafimer Hospital, the university hospital in Stockholm, whose X-ray department moved to a separate house nearby in 1910. This was named Radiohemmet (Radio Home). Subsequently, both the city of Stockholm and the state of Sweden became involved in radiotherapy. In 1916 a new building was opened, with 34 beds for patients.
For the history of radiotherapy in Sweden, 1928 was a crucial year. On the occasion of the seventieth birthday of King Gustav V, the Swedish people offered him a present of 6 million crowns. This gift was passed on to the Swedish organization 58 also Jacques Bandaline, La Ton van Helvoort for cancer control and was used, among other things, to establish centralized cancer treatment institutions.6' Gosta Forssell became an important spokesman for those who defended the centralization of cancer control as the most effective way of organizing it.
In the United States, the availability of radium had improved after the mid-1910s, when the US Bureau of Mines and the American Institute of Radium-founded by Howard Kelley, a gynaecologist from Baltimore, and the engineer James Douglas-set up a radium production plant in Denver. Until 1922, when uranium ores were discovered in the Belgian Congo, the main part of all the radium in the world was to be found in the United States. James Douglas donated his share of the company-in the form of several grams of radium-to the Memorial Hospital for the Treatment of Cancer and Allied Diseases in New York.62 Headed by the surgeon Henry H Janeway and the physicist Gioacchino Failla, the Memorial became a centre of expertise for radium therapy.63 Besides the Memorial at New York, the Collis P Huntington Memorial Cancer Hospital in Boston was also an important centre.
In England, N S Finzi, the author of the first 1913 textbook on radium therapy, brought together 600 mg of radium for the treatment of a millionaire suffering from cancer of the bladder in 1911. During the First World War, radium was used in aeroplanes, for dials and indicators, and at the close of the war the Royal Air Force had a surplus of 5 grams, which was donated to the Medical Research Council. The MRC loaned the entire 5 grams to the Middlesex Hospital in London, predominantly for the treatment of cancer but also for experimental work. However, within two years the radium was split and divided among several clinical institutions. In 1929 the British National Radium Commission was formed to control the distribution of radium among other things to a dozen regional cancer treatment centres.54
From this brief outline of developments in four countries, we can conclude that in the second half of the 1920s important cancer hospitals and cancer research institutions were set up in each of them. The role of philanthropy in the development of cancer control in all these countries is most remarkable. The precious nature of radium and its scarcity were important factors in the centralization of radium therapy at various levels. In centralized cancer institutes, surgeons and radiotherapists were more or less forced to co-operate. A chronicler of radiotherapy in Sweden stated that because of the existence of consultative structures in that country "there has 61 The developments abroad outlined in the previous section highlighted the sore point of radium shortage in Germany. In the press this became known as the "radium problem". In order to delineate a policy regarding the future of radiotherapy in Germany, -urging cancer patients to visit a doctor as soon as possible; -further development and intensification of existing cancer research institutes; -the creation of centralized institutes, possibly linked to the cancer institutes at Berlin and Heidelberg so that telecurietherapy could be effected (in all about 6 grams of radium were thought to be needed); -establishment of smaller offices for cancer consultation and treatment with other forms of radiotherapy; -centralization of radium and mesothorium supplies, and organization of a rational distribution of the capacity in radiotherapy;
-regulating the handling and use of radioactive substances such as radium and mesothorium, so that only trained personnel and therapists would be allowed to work with them.70
Similar themes were discussed on 31 May 1930 at a hearing organized by the Landesgesundheitsrat (County Public Health Board) on the future of cancer control. The debate was opened by contributions from Ernst Putter (administrative director of the Charite) and Ferdinand Blumenthal.7' The latter pleaded for a centralized organization of radiotherapy to make sure that education, training and quality control could be dealt with effectively. Blumenthal concluded that radiotherapy had been introduced too rapidly, so that there was insufficient supervision of a risky, not to say potentially dangerous, technique. He argued that everyone had access to capable surgeons but that things were different for radiotherapy in general, and radium therapy in particular: "It would be a gross underestimation of X-ray and radium treatment to believe that it would suffice to put enough radium into the hands of an otherwise competent physician to achieve satisfactory radiotherapy."72 Subsequently, the purchase of and control over radium and mesothorium were discussed and Blumenthal argued that this necessitated central institutions. Fernbestrahlungen or deep therapy (as opposed to direct application, also known as "brachytherapy") was not required so frequently that facilities had to be available everywhere. Blumenthal's conclusion was that the developments abroad should be taken as an example: "We should therefore proceed along the same lines as Sweden and France, i.e., concentrating the equipment for high-dosage telecurietherapy in a few places, while most cases are treated with smaller doses in those same or other places."73 Moreover, Blumenthal argued for the establishment of a Prufungskommission (assessment committee), which would monitor the expertise of Radiotherapy in Pre-Second World War Germany radiotherapy. This would result in better protection of patients as well as doctors and therapists against the harmful effects of radioactive rays. All this had to be laid down in legislation.
The work of the radium committee of the DZK testifies to the importance radiotherapy had gained in the treatment of cancer. Not only were the pros and cons of introducing regulation of radiotherapy discussed but also who would have jurisdiction over the technique. Walter Stoeckel, head ofthe Universitats-Frauenklinik (University Gynaecological Clinic) of the Charite, warned against the consequences of centralizing radiotherapy: "Founding centralized cancer institutes would provoke further opposition from all sides, including specialists and specialized institutes. It would arouse the not unreasonable fear that a major part of their own work might be taken away from them."74 He was referring to the surgeons, gynaecologists, dermatologists, oto-laryngologists and to a lesser extent orthopaedists. These specialists claimed that cancer as a disease of a specific organ had to be treated by those who were experts in that particular medical domain. Thus, cancer of the cervix fell under the jurisdiction of gynaecologists. According to Stoeckel, this situation was the result of a historical process which should not be interfered with by creating a new specialism encompassing different fields of expertise. Stoeckel clearly opposed the centralization of radiotherapy striven for by Blumenthal, but the latter secured support from, for instance, the Cologne radiologist Werner Teschendorf, who openly advocated the establishment of special clinics for radiotherapy. Teschendorf claimed that much "cancer therapy" was being lost through injudicious use.75
In 1931 Blumenthal and Teschendorf came under severe attack from the Medical Faculty of the University of Frankfurt am Main, an attack articulated by its dean, A Loos.76 The immediate cause which brought the different points of view into the open was the formation of the ReichsausschuB fur Krebsbekampfung. Its inauguration on 25 February 1931 was a most important step, because it marked the beginning of government participation in cancer control. And, interestingly, the committee's chairman Bruno Dammann and secretary Felix Gruneisen seemed to opt for the centralization of radiotherapy as Blumenthal had advocated. 77 Loos accused Blumenthal of attempts to withdraw the treatment of cancer patients from the disciplines that claimed jurisdiction over diseased organs and to establish centralized cancer hospitals and institutes. This, he claimed, would be harmful for the training of doctors and specialists. Loos referred to an article written by Frankfurt's Hans Holfelder, which defended local integration of radiotherapy with Ton van Helvoort the surgical specialisms.78 Holfelder's institute was, on the one hand, a centralized establishment with large spaces for the megavolt X-ray devices, while on the other it was integrated with the university's surgical clinic headed by Victor Schmieden. Holfelder stated that the X-ray department performed no surgery of whatever kind, as this was the proper domain of the Surgical Clinic.79
Criticism of Blumenthal became even sharper when Germany's most prominent surgeons, Hans Kuittner (Breslau), Ferdinand Sauerbruch (Charite, Berlin) and Victor Schmieden (Frankfurt am Main), openly joined in the conflict, claiming that surgeons were deliberately being excluded from the ReichsausschuB.80 If Blumenthal was critical about the legitimacy of cancer surgery in many cases, surgeons were most critical about the results claimed by the radiotherapists. They referred to patients who "would develop into hopeless cases as a result of useless radiotherapy and so be lost to cure". In their view, the radiotherapist was only to be called in after the surgeon had given permission: "Generally speaking, the radiotherapist should be called in only after the possibilities for surgical treatment have been exhausted or have been rejected on good grounds."8'
In July 1932, the medical faculty of Berlin University decided to cut the budget of Blumenthal's Institut fur Krebsforschung by 20,000 Marks, of which one-fifth affected Rhoda Erdmann's Institut fur experimentelle Zellforschung (Institute for Experimental Cell Research). Although the latter was independent, it still was financially tied to the IfK. Blumenthal wrote to Charite's administrative director Alfred Kuhnert saying that a budget cut of this magnitude would in fact imply the end of the IfK as a research institute. In Blumenthal's view, the attack on his Institute was inspired by the competition between the IfK and the regular clinics and institutes where radiotherapeutic devices for the treatment of cancer patients were also available. The argument ofhis adversaries, Blumenthal claimed, was that "radiative treatment ofcancer could just as well be performed and developed at the surgical clinics".82 He concluded that "the independence ofcancer research and cancer treatment in Germany [appeared to be] under attack from two different directions-pathology and surgery".83
As mentioned above, Blumenthal devoted his experimental cancer research to a wide range of models. The conclusions drawn from these studies for the etiology of human cancer were unacceptable to many clinicians and orthodox pathologists. Krebsbekampfung', Med. Welt, 1931 , 5: 1932 HUA Char. Dir. nr. 953, 246-53, p. 248. 981-5 . In response to this, the chairman of the 83Ibid., p. 248. ReichsausschuB, Bruno Dammann, quickly Radiotherapy in Pre-Second World War Germany give an example, the surgeon Victor Schmieden, co-author of the 1931 attack on Blumenthal, had written a few years before:
It is alien to the clinician's mode of thinking not to rely on conclusive evidence from human materials, but time and again to be referred to mammals, thence to birds, thence to coldblooded animals and even to plants (sunflowers etc.)... . [WMe must warn against attaching too much value to comparative observations from the animal or plant kingdom.'M This comment was written in response to the publicity that the research on cancer viruses had received in the mid-1920s.85 And in 1937 Ferdinand Sauerbruch, co-author of an anti-Blumenthal article, formulated his hesitation about animal experiments as follows: "Clinicians will be particularly apprehensive about simply transferring the results of animal experiments to human pathology and about generalizing and overestimating the extent of their significance."86 Therefore, when Blumenthal wrote that independent cancer work was being attacked by pathology and surgery he had in mind both his research programme and the radiotherapeutic treatment of cancer patients.
The warm relationship between the chairman and the secretary of the ReichsausschuB3 on the one hand and Ferdinand Blumenthal on the other had flagged and the committee now established firm ties with the Deutsche Gesellschaft fur Gynakologie (German Gynaecological Society) 
Ton van Helvoort
Confficting Views on the Continuation of the Institut fur Krebsforschung After the almost complete dismantling of the IfK in April 1933, the dean of the Medical Faculty of the University of Berlin, Hermann Gocht, tried to delineate new aims for the Institute. He was the chairman of the Deutsche Orthopadische Gesellschaft (German Orthopaedic Society) and was greatly involved in the development of radiology because of the crucial role X-ray diagnostics played in his profession.89 Gocht sought advice from several experts, including the gynaecologist Walter Stoeckel (Charite), the surgeon Victor Schmieden (Frankfurt am Main) and the radiologists Gosta Forssell (Stockholm) and Hans Schinz (Zurich).
In 1930, Stoeckel had warned that attempts to centralize radiotherapy would meet with serious resistance from medical specialists. And in his advice to Gocht he was also very outspoken against a centralized radiotherapeutic institute at the Charite:
Whenever the founding of a centralized institute for radiotherapy or the establishment of a cancer hospital was discussed, the faculty has emphatically rejected the centralization of either radiotherapy or cancer treatment. It is absolutely essential that each clinic retains the right and has the necessary equipment to irradiate patients and treat cancers. This necessity derives especially from the fact that radiotherapists are insufficiently trained in either diagnostics or therapy to solve the problems that need to be solved with regard to cancer diagnostics and cancer therapy.
Although Stoeckel admitted that radiotherapy had its place in the treatment of cancer, he felt, nevertheless, that the main responsibility was with the clinician: "It is only the clinician who is capable of assessing and implementing this kind of therapy, not the radiotherapist". Stoeckel did not object to the IfK as a research institute, as long as it did not have therapy as its main objective.'
The Frankfurt surgeon Victor Schmieden, who with Kuittner and Sauerbruch had criticized Blumenthal openly, was asked for advice too. His view was typical of a surgeon: (i) the cancer patient had to be treated by the specialist with competence over the organ or organs affected; (ii) surgery had to be the first line oftreatment; (iii) cancer treatment should never be based on a one-sided radiotherapeutic approach. Schmieden had always been offended by the IfK's pretending to be a therapeutic institute:9' I have also always resented the presence in the Luisenstrasse in Berlin ofan institute which openly advertises itself to the public at large as a therapeutic institute for tumour diseases.... The real tumour diseases, especially cancer, however, are so intimately linked to the various clinical disciplines that it would be impossible to tear these types ofdisease away from internal medicine, surgery, gynaecology, laryngology, etc. and place their diagnosis and treatment under the responsibility of a special therapist who looks only at this aspect. Radiotherapy in Pre-Second World War Germany Schmieden held the opinion that since surgery was in the vanguard of cancer treatment, the cancer patient should seek refuge in a combination of surgical and radiotherapeutic interventions "but not in a purely surgical, nor in a purely radiological therapy".92
Stoeckel and Schmieden represented the established disciplines, but radiologists were consulted too. Gosta Forssell, head of the Sophiahemmets Rontgeninstitut at Stockholm, persevered in pleading for the centralization of radiotherapy. He advised performing radiotherapy in an independent clinic with an outpatient department, although in "carefully organized collaboration" with the other clinics where surgery was practised. He advised Gocht to transfer the experimental research to the Charite's Pathological Institute.93
The second radiotherapist consulted was Hans R Schinz, professor of medical radiology at Zurich and chairman of the Fourth International Congress of Radiology, held in Zurich in 1934. In his advice to Gocht, Schinz clearly expressed sympathetic feelings towards National Socialism, so a pro-Blumenthal position was hardly to be expected from him. He stated that now that the National Socialist revolution in Germany had succeeded, the country could catch up with such countries as Sweden with its Radiohemmet, the United States with its Memorial Hospital, Milan with its Instituto del Cancro and Paris with its Institut du Radium. Schinz concluded that cancer surgery in Germany was well organized, unlike treatment by radiotherapy. He held the view that centralization would be inevitable: "All leading radiotherapists support the centralization of radiotherapy." In the Romance, Anglo-American and Scandinavian countries, centralized cancer institutes had been founded, as it was impossible for a radiotherapist to work efficiently "in an institute which functions only as a nursing home for incurable cancer patients". With regard to the situation in Germany, his judgement was most critical: "The decentralization undertaken in most places in Germany has yielded disappointing results, and despite our great sympathy for Germany it must be said that, except as regards gynaecological radiotherapy, this has caused Germany, which has always marched at the forefront of science, to lag behind." Schinz was familiar with the Berlin Institut fuir Krebsforschung and believed that the "existing cancer institute should not only be continued but should be expanded into a radiotherapeutic cancer centre, which should primarily be led by a radiotherapist". In such an institute there was no need for extensive operations, as surgery and radiotherapy were independent disciplines: "A clear separation between these two treatment modalities should and can be made."94 Schinz's views on the Berlin IfK were very similar to the objectives set out by Blumenthal. The consultations by Gocht resulted in the same division along party lines as had existed while Blumenthal was director of the Institute. Radiotherapists strove for centralization of treatment facilities, while the medical specialists defended their jurisdiction over the use of radiotherapy.
92Ibid., pp. 29-30. With regard to specialization and co-operation, Forssell took the following position: "It is no longer a matter of whether cancer treatment should be centralized, but of the extent to which and the principles on which this is to be implemented".95 In the case of treatment with radium, Forssell held that this should be performed in central clinics for radiotherapy. Sauerbruch, who represented clinical medicine, understood the tension between surgery and radiotherapy. He saw it as inevitable "that there was initially a certain rivalry between the two sister disciplines, notwithstanding their great similarity in many fundamental respects. Roentgenology tried to contest the authority of the older surgical discipline, while the latter often out of prejudice denied or underestimated the prospects of radiology and hence rejected it". And with reference to Forssell's keynote address, Sauerbruch expressed his gratitude for the "guidelines provided by his ground-breaking work, though certain details will have to be adapted to the circumstances".96 But the crucial issue was of course which "details" would have to be adapted in order to meet the German situation.
The way Sauerbruch formulated the problem, it seemed as if the question was over which of the two techniques-the use of the scalpel or radiotherapy-was most beneficial to the cancer patient. But, as will have become clear from this account, it was not so much a dispute over what constituted the best technique but under whose jurisdiction radiotherapy fell.
In view of the contradictory recommendations Hermann Gocht received regarding the continuation of the Institut fur Krebsforschung, it is not surprising that no firm decision was reached. Temporarily, Sauerbruch was appointed curator, while Hans Auler was in charge of the day-to-day running of the Institute. Under Sauerbruch, experimental cancer research entered new avenues. The experimental models studied by Blumenthal were almost all abandoned. Sauerbruch believed that the course of a disease was determined by the body as a whole. This constitutional or pathophysiological notion of disease had become fashionable since the 1920s and had resulted in dietary studies and hormone research. Thus Sauerbruch and his coworkers had developed a dietary treatment for tuberculosis.97 In cancer, disturbances Radiotherapy in Pre-Second World War Germany of the hormone balance, for example as a consequence of advancing age, were assumed to play a role. In his paper 'Die Bedeutung von Sexualstorungen fur die Entstehung von Geschwuilsten' (The impact of sexual disorders on the genesis of tumours), Sauerbruch argued that the anatomical orientation had dominated cancer research too much, "while general pathological disorders of the organism as a whole were neglected".98 The physiological approach advocated by Sauerbruch was studied in more detail by Hans Auler, who did research on, for instance, the influence of climate on the genesis of cancer in laboratory animals. 9 As stated above, the ReichsausschuB3 fur Krebsbekampfung was initially biased in favour of the centralization of radiotherapy, a point of view that was abandoned under pressure from the German Societies for Gynaecology and Surgery. In spite of this, the committee urged the National Socialist government to create three professorships of radiology in 1935.'°They were situated in Hamburg, Cologne and Leipzig and it will be no surprise that Berlin was not included in the list.
In the late 1930s the conflict over radiotherapy in relation to the clinical specialisms was as heated as it had been a decade before. At the last meeting of the Deutsche Rontgengesellschaft (German Roentgen Society) before the Second World War, held in May 1939 at Stuttgart, the problem was addressed again. Hans Holfelder-who in 1931 had pleaded for local radiological institutes, integrated with surgical departments-now advocated the creation of centralized institutes for roentgenology, not only for radiotherapy but for X-ray diagnosis as well. Again, the representatives of the clinical specialisms objected strongly. Alfred Schittenhelm of the Deutsche Gesellschaft fur Innere Medizin (German Society for Internal Medicine) contended that "the various specialized clinics [should] be allowed to keep their own X-ray institutes". Martin Kirschner, representing the Deutsche Gesellschaft fur Chirurgie, provokingly stated that roentgenologists were aiming "to establish for themselves a free territory to work in, without any competition". And Heinrich Martius ofthe Deutsche Gesellschaft fur Gynakologie claimed that the gynaecologist not only had to do his own X-ray diagnostics, but should also "retain control of his own radiotherapy".'°'
In 1939, the X-ray department of Sauerbruch's Surgical Institute merged with that of the Institut fur Krebsforschung.'02 Meanwhile, the clinical department of the IfK Ton van Helvoort was deteriorating rapidly. After a complaint from a patient in 1942, the head of the Gesundheitsamt Berlin-Mitte wrote: "In any case, the nursing ward of the institute in its present state is a disgrace and should be closed down by the police."'03 This meant an inglorious end to an institute that had been made internationally renowned by Ferdinand Blumenthal.
Scalpel or Rays?
The present essay has discussed how a new treatment modality for cancerradiotherapy-was introduced and how this technique had to struggle for a niche of its own. It had to compete with orthodox therapy, i.e. surgery. The development of radiotherapy in Germany, and the history of the Institut fiur Krebsforschung of the Berlin Charite in particular, constitutes an interesting case study because the course taken differed from that in surrounding countries. Since centralized cancer institutes had been established in France and Sweden, Ferdinand Blumenthal strove for a similar role for his Institut fiur Krebsforschung; however, this met with vigorous resistance from the orthodox clinical specialisms.
That the struggle between medical specialists and radiotherapists trying to establish an independent specialism of their own was so intense and protracted was related to several specific characteristics of X-ray and radium technology, which applied not only in Berlin and in Germany as a whole, but in other countries as well. First, the introduction of therapeutic X-ray devices developed from X-ray diagnostics, the latter technique being of great importance to many medical specialisms. As the X-ray tube and related appliances were relatively cheap, X-ray diagnostics was widely available. When, in the early twentieth century, X-ray therapy ofcancer was initiated, this seemed to be a change ofdegree rather than ofkind. Second, like X-ray therapy, radium therapy was a technique which was highly "democratic". Although radium and mesothorium were costly, in many cases some tens or hundreds ofmilligrams were enough to produce excitingly high rates ofcure. The situation changed when in countries such as England, France, Sweden and the United States impressive results were obtained by using "radium bombs", which contained grams of radium. The radium shortage which had been a problem in Germany from the beginning of the twentieth century was then acutely felt. Or, as Blumenthal said at a cancer conference in 1930: "there is no other medical discipline . . . where this lack of funds has been so noticeable-I refer to the high price of radium-and where we have therefore been lagging behind other nations so seriously in the research on and treatment of cancer."'04 To sum up, radium was both a "democratic agent" and a "centralizing agent", depending on the form of therapy, i.e. brachytherapy or Fernbestrahlung (deep therapy).
Third, another argument for centralizing radiotherapy stemmed from the inherent hazards of radioactive rays, which constituted a health problem for the therapist as well as for the patient. This required several precautionary measures: (i) radiotherapists had to be educated and trained to prevent dilettantism; (ii) Krebsforschung, 1930, 31: 632-6, p. 636. 
